Healthcare Distribution Alliance – Patients Move Us.
SEARCH
FEATURED UPCOMING EVENTS
2019 Traceability Seminar
October 21 to 23, 2019
| Marriott Wardman Park, Washington, DC
HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones as well as innovative approaches and lessons learned as distributors,...
Register
View All Events
2020 Distribution Management Conference and Expo
March 8 to 11, 2020
| Marriott Marquis San Diego Marina, San Diego, Calif.
The Distribution Management Conference (DMC) and Expo is HDA's largest supply chain education event, attended by 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical...
View All Events
MEMBER SPOTLIGHT
Henry Schein, Inc. (NASDAQ: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs nearly 19,000 Team Schein Members and serves more than one million customers.
IN THE NEWS
July 31, 2019
HDA Statement on HHS-FDA "Safe Importation Action Plan"
July 16, 2019
HDA Statement on Release of DEA ARCOS Data
ISSUES IN DISTRIBUTION
Pharmaceutical Traceability
HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription...
READ MORE
Prescription Drug Abuse and Diversion
HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...
READ MORE
Importation of Prescription Medicines
HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...
READ MORE
Taxes
HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted...
READ MORE
